October 16, 2020
Japan rolled out a reimbursement incentive for biosimilars earlier this year, but the COVID-19 pandemic appears to be taking a toll on this measure as frontline clinicians are too busy to meet criteria for claiming the fee. Junichi Kawakami, vice...read more